Rivulet Media Inc (fka RIVU)

[ADVFN_franknstein]

BMSN now owns at least a 51% Controlling Interest in RGBP

Wrong! Nothing changed!

From the BMSN 10-Q filed 2015-08-11

Through its controlled subsidiary, Regen BioPharma, Inc., the Company intends to engage primarily in the development of regenerative medical applications which we intend to license from other entities up to the point of successful completion of Phase I and or Phase II clinical trials after which we would either attempt to sell or license those developed applications or, alternatively, advance the application further to Phase III clinical trials The Company holds 18.3% of the equity and 70% of the voting power of Regen BioPharma, Inc.

70% of the voting power is enough for controlling the company.